Visiopharm Precision Pathology Software

Visiopharm A/S is an AI-driven precision pathology software company with its address in Hoersholm, Denmark. Its site says the software combines 20 years of experience with AI for research and diagnostics.

The portfolio includes Phenoplex for spatial biology, Discovery for training deep learning apps, Tissuealign and Tissuearray, Qualitopix for IHC staining consistency and IVDR-certified APPs for breast, lung and prostate biomarker assessment. The platform offers over 130 modular image analysis APPs and integrates with IMS and LIMS systems.

• Phenoplex: image analysis for spatial biology.
• Discovery: tissue research and deep learning app training.
• CE-IVD APPs: biomarker assessment for breast, lung and prostate cancer.
• Qualitopix: IHC staining consistency monitoring.
• APP Center: over 130 modular image analysis units.
• Tissuealign and Tissuearray: slide alignment and tissue microarray analysis.

A cancer hospital can score HER2 or Ki67 on digital slides with IVDR-cleared APPs. A CRO can quantify biomarkers in clinical trial tissue. A research institute can run multiplex spatial analysis with Phenoplex.

IVDR-certified APPs support diagnostic use for breast, lung and prostate biomarkers. Modular APPs and pretrained Quickstart APPs shorten development of new analyses. EN ISO 13485:2016 certification supports quality reviews. Integration with IMS and LIMS fits existing laboratory workflows.

Pathology AI is shifting toward regulated companion diagnostics such as PD-L1 and Ki67 scoring. Vietnamese oncology hospitals and CROs running IHC-based trials can use validated image analysis to improve scoring consistency as digital slide scanning spreads.

Address: Agern Alle 24, Hoersholm, Denmark. Press release page lists Grundium acquiring Visiopharm (2026-05-21), Stratipath partnership (2025-09-02), Indica Labs integration (2025-04-09) and Cell Signaling Technology partnership (2025-04-08). EN ISO 13485:2016 certificate. Founding year not stated.